Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SUMIT GAUR

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1609972801
CMS profile
118893
Location
EL PASO, TX

General Payments · PY2018–2024

$3,190.12

  • Reported across 85 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,895.48

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Long term medical supply or device loan $1,196.40 12
Food and Beverage $449.08 20
Grant $250.00 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $188.79 12
PY2019 $212.28 14
PY2020 $129.18 3
PY2021 $62.10 4
PY2022 $78.63 4
PY2023 $623.66 15
PY2024 $1,895.48 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ARRAY BIOPHARMA INC $21.75 08/02/2024 Food and Beverage Undisputed 01/23/2026 1131337737 CMS
AstraZeneca Pharmaceuticals LP $250.00 01/29/2024 Grant Undisputed 01/23/2026 1105347146 CMS
AstraZeneca Pharmaceuticals LP $14.78 02/21/2024 Food and Beverage Undisputed 01/23/2026 1105259036 CMS
AstraZeneca Pharmaceuticals LP $19.23 03/02/2024 Food and Beverage Undisputed 01/23/2026 1105562564 CMS
AstraZeneca Pharmaceuticals LP $51.03 09/11/2024 Food and Beverage Undisputed 01/23/2026 1105823309 CMS
E.R. Squibb & Sons, L.L.C. $18.61 02/28/2024 Food and Beverage Undisputed 01/23/2026 1101617762 CMS
E.R. Squibb & Sons, L.L.C. $22.95 12/02/2024 Food and Beverage Undisputed 01/23/2026 1101617920 CMS
Gilead Sciences, Inc. $17.02 03/27/2024 Food and Beverage Undisputed 01/23/2026 1133803584 CMS
Gilead Sciences, Inc. $30.16 05/08/2024 Food and Beverage Undisputed 01/23/2026 1133803586 CMS
Gilead Sciences, Inc. $22.26 08/14/2024 Food and Beverage Undisputed 01/23/2026 1133803588 CMS
Gilead Sciences, Inc. $24.70 08/29/2024 Food and Beverage Undisputed 01/23/2026 1133803590 CMS
Janssen Biotech, Inc. $25.89 02/14/2024 Food and Beverage Undisputed 01/23/2026 1078711524 CMS
Lilly USA, LLC $23.74 08/28/2024 Food and Beverage Undisputed 01/23/2026 1135351451 CMS
Merck Sharp & Dohme LLC $19.84 05/29/2024 Food and Beverage Undisputed 01/23/2026 1141610872 CMS
Merck Sharp & Dohme LLC $21.40 06/26/2024 Food and Beverage Undisputed 01/23/2026 1141610746 CMS
Merck Sharp & Dohme LLC $18.83 08/29/2024 Food and Beverage Undisputed 01/23/2026 1141610744 CMS
Merck Sharp & Dohme LLC $19.82 10/08/2024 Food and Beverage Undisputed 01/23/2026 1141840928 CMS
Novartis Pharmaceuticals Corporation $99.70 01/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086837389 CMS
Novartis Pharmaceuticals Corporation $25.14 01/24/2024 Food and Beverage Undisputed 01/23/2026 1086837343 CMS
Novartis Pharmaceuticals Corporation $99.70 02/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086837391 CMS
Novartis Pharmaceuticals Corporation $99.70 03/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086837393 CMS
Novartis Pharmaceuticals Corporation $99.70 04/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086837395 CMS
Novartis Pharmaceuticals Corporation $99.70 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086837397 CMS
Novartis Pharmaceuticals Corporation $99.70 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086837399 CMS
Novartis Pharmaceuticals Corporation $99.70 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086837437 CMS
Novartis Pharmaceuticals Corporation $99.70 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086837433 CMS
Novartis Pharmaceuticals Corporation $99.70 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086837435 CMS
Novartis Pharmaceuticals Corporation $99.70 10/17/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086837443 CMS
Novartis Pharmaceuticals Corporation $16.30 11/01/2024 Food and Beverage Undisputed 01/23/2026 1086837407 CMS
Novartis Pharmaceuticals Corporation $99.70 11/14/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086837441 CMS
Novartis Pharmaceuticals Corporation $99.70 12/10/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086837451 CMS
Novartis Pharmaceuticals Corporation $18.11 12/11/2024 Food and Beverage Undisputed 01/23/2026 1086837415 CMS
Tempus AI, Inc $17.52 01/02/2024 Food and Beverage Undisputed 01/23/2026 1150165022 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.